Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future DirectionsAZEREDO, Francine Johansson; COSTA, Teresa Dalla; DERENDORF, Hartmut et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 205-212, issn 0312-5963, 8 p.Article

On the prediction of the human response : A recycled mechanistic pharmacokinetic/pharmacodynamic approachMENO-TETANG, Guy M. L; LOWE, Philip J.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 182-192, issn 1742-7835, 11 p.Article

Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating AgentsDOSHI, Sameer; KRZYZANSKI, Wojciech; YUE, Susan et al.Clinical pharmacokinetics. 2013, Vol 52, Num 12, pp 1063-1083, issn 0312-5963, 21 p.Article

Development ofTranslational Pharmacokinetic-Pharmacodynamic ModelsMAGER, D. E; JUSKO, W. J.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 6, pp 909-912, issn 0009-9236, 4 p.Article

Pharmacokinetic/pharmacodynamic modelling in oncological drug developmentKARLSSON, Mats O; ANEHALL, Therese; FRIBERG, Lena E et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 206-211, issn 1742-7835, 6 p.Article

Antibody pharmacokinetics and pharmacodynamicsLOBO, Evelyn D; HANSEN, Ryan J; BALTHASAR, Joseph P et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 11, pp 2645-2668, issn 0022-3549, 24 p.Article

Monoclonal Antibody Pharmacokinetics and PharmacodynamicsWANG, W; WANG, E. Q; BALTHASAR, J. P et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 5, pp 548-558, issn 0009-9236, 11 p.Article

Species differences in Troxacitabine pharmacokinetics and pharmacodynamics: Implications for clinical developmentGOURDEAU, Henriette; LEBLOND, Lorraine; HAMELIN, Bettina et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7692-7702, issn 1078-0432, 11 p.Article

Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric PatientsYEE, Donald L; O'BRIEN, Sarah H; YOUNG, Guy et al.Clinical pharmacokinetics. 2013, Vol 52, Num 11, pp 967-980, issn 0312-5963, 14 p.Article

The odds that clinically unrecognized poor or partial adherence confuses population pharmacokinetic/pharmacodynamic analysesVRIJENS, Bernard; GROSS, Robert; URQUHART, John et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 225-227, issn 1742-7835, 3 p.Article

Pharmacokinetic/pharmacodynamic relationships: Basic conceptsTROCONIZ, I. F.Methods and findings in experimental and clinical pharmacology. 2002, Vol 24, pp 125-126, issn 0379-0355, 2 p., SUPDConference Paper

Bioequivalence and generic prescribing : an industrial viewPIDGEN, A.Journal of pharmacy and pharmacology. 1996, Vol 48, Num 1, pp 11-16, issn 0022-3573Conference Paper

Pharmacokinetic and Pharmacodynamic Profile of Empagliflozin, a Sodium Glucose Co-Transporter 2 InhibitorSCHEEN, André J.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 213-225, issn 0312-5963, 13 p.Article

Improved Cellular Pharmacokinetics and Pharmacodynamics Underlie the Wide Anticancer Activity of SagopiloneHOFFMANN, Jens; VILALE, Ilio; PANARETAKIS, Theocharis et al.Cancer research (Baltimore). 2008, Vol 68, Num 13, pp 5301-5308, issn 0008-5472, 8 p.Article

Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligandBING WANG; NICHOL, Janet L; SULLIVAN, John T et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 628-638, issn 0009-9236, 11 p.Article

Grounds for the integration of pharmacokinetic-pharmacodynamic dataBARBANOJ, M. J; SALAZAR, G; MORTE, A et al.Methods and findings in experimental and clinical pharmacology. 1996, Vol 18, pp 43-45, issn 0379-0355, SUPCConference Paper

Overview : Issues concerning the pharmacology of multiple drug regimensLIETMAN, P. S.Antiviral research. 1996, Vol 29, Num 1, issn 0166-3542, p. 65Conference Paper

Clinical Pharmacokinetic and Pharmacodynamic Profile of RivaroxabanMUECK, Wolfgang; STAMPFUSS, Jan; KUBITZA, Dagmar et al.Clinical pharmacokinetics. 2014, Vol 53, Num 1, pp 1-16, issn 0312-5963, 16 p.Article

Pharmacokinetics and Pharmacodynamics of Antifungals in Children and their Clinical ImplicationsSTOCKMANN, Chris; CONSTANCE, Jonathan E; ROBERTS, Jessica K et al.Clinical pharmacokinetics. 2014, Vol 53, Num 5, pp 429-454, issn 0312-5963, 26 p.Article

Drug Interactions with the Newer Antiepileptic Drugs (AEDs)—Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDsPATSALOS, Philip N.Clinical pharmacokinetics. 2013, Vol 52, Num 11, pp 927-966, issn 0312-5963, 40 p.Article

Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic PeptidesLEI DIAO; MEIBOHM, Bernd.Clinical pharmacokinetics. 2013, Vol 52, Num 10, pp 855-868, issn 0312-5963, 14 p.Article

Pharmacokinetics, Pharmacodynamics and Physiologically-Based Pharmacokinetic Modelling of Monoclonal AntibodiesDOSTALEK, Miroslav; GARDNER, Iain; GURBAXANI, Brian M et al.Clinical pharmacokinetics. 2013, Vol 52, Num 2, pp 83-124, issn 0312-5963, 42 p.Article

Pharmacokinetic and Pharmacodynamic Considerations in Antimalarial Dose OptimizationWHITE, Nicholas J.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5792-5807, issn 0066-4804, 16 p.Article

Folic Acid and L-5-Methyltetrahydrofolate: Comparison of Clinical Pharmacokinetics and PharmacodynamicsPIETRZIK, Klaus; BAILEY, Lynn; SHANE, Barry et al.Clinical pharmacokinetics. 2010, Vol 49, Num 8, pp 535-548, issn 0312-5963, 14 p.Article

Pharmacokinetic and Pharmacodynamic Parameters of Antimicrobials: Potential for Providing Dosing Regimens that Are Less Vulnerable to ResistanceADEMBRI, Chiara; NOVELLI, Andrea.Clinical pharmacokinetics. 2009, Vol 48, Num 8, pp 517-528, issn 0312-5963, 12 p.Article